Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to 0.46.

  • Palisade Bio's Equity Ratio fell 3492.01% to 0.46 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46, marking a year-over-year decrease of 3492.01%. This contributed to the annual value of 0.69 for FY2024, which is 1446.79% down from last year.
  • Latest data reveals that Palisade Bio reported Equity Ratio of 0.46 as of Q3 2025, which was down 3492.01% from 0.39 recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Equity Ratio registered a high of 0.9 during Q1 2023, and its lowest value of 2.25 during Q1 2021.
  • Its 5-year average for Equity Ratio is 0.44, with a median of 0.7 in 2024.
  • Its Equity Ratio has fluctuated over the past 5 years, first tumbled by 35623.35% in 2021, then skyrocketed by 21724.78% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's Equity Ratio stood at 0.24 in 2021, then surged by 228.66% to 0.79 in 2022, then increased by 1.69% to 0.81 in 2023, then fell by 14.47% to 0.69 in 2024, then plummeted by 33.11% to 0.46 in 2025.
  • Its Equity Ratio was 0.46 in Q3 2025, compared to 0.39 in Q2 2025 and 0.65 in Q1 2025.